Antimicrobial Resistance: formulation of the response in the global health context
Main Author: | |
---|---|
Publication Date: | 2020 |
Other Authors: | , , , |
Format: | Article |
Language: | por eng |
Source: | Saude em Debate |
Download full: | https://www.saudeemdebate.org.br/sed/article/view/3519 |
Summary: | Antimicrobial Resistance (AMR) has proved to be a major public health problem at the global level. This paper examined the formulation of the response to AMR negotiated through the World Health Organization (WHO) by its Member States. Related WHO reports and resolutions from 1998 to 2019 were analysed. The findings indicate that, from 2014 on, more robust conditions were established for approval of a Global Action Plan on AMR, encompassing the concept of One Health and involving otherinternational entities (FAO, OIE, WTO and Unep). Content analysis and various analytical frameworks, considering two economic sectors (the livestock and pharmaceutical industries), proved relevant to illustrating the complexity of the issue, reinforcing its global importance and acknowledging the extent of antibiotic use in animals and the gaps in technological innovation. As the WHO is not only an important agent for mobilizing the response to AMR at the global level, but – despite a context of de-funding – has guaranteed a budget for action in this area, it is concluded that the public health perspective should prevail in the response to AMR. |
id |
CBES-1_f75cea0221b29ee83379c10f173865df |
---|---|
oai_identifier_str |
oai:ojs.saudeemdebate.emnuvens.com.br:article/3519 |
network_acronym_str |
CBES-1 |
network_name_str |
Saude em Debate |
repository_id_str |
|
spelling |
Antimicrobial Resistance: formulation of the response in the global health contextRESISTENCIA A LOS ANTIMICROBIANOS: LA FORMULACION DE LA RESPUESTA EN EL ÁMBITO DE LA SALUD GLOBALResistência a Antimicrobianos: a formulação da resposta no âmbito da saúde globalSaúde global. Resistência microbiana a medicamentos. Saúde Única. Indústria agropecuária. Produção de droga sem interesse comercial.Global health. Drug resistance, microbial. One Health. Livestock industry. Orphan drug production.Salud GlobalFarmacorresistencia microbianaSalud ÚnicaIndustria AgropecuariaProducción de Medicamentos sin Interés ComercialAntimicrobial Resistance (AMR) has proved to be a major public health problem at the global level. This paper examined the formulation of the response to AMR negotiated through the World Health Organization (WHO) by its Member States. Related WHO reports and resolutions from 1998 to 2019 were analysed. The findings indicate that, from 2014 on, more robust conditions were established for approval of a Global Action Plan on AMR, encompassing the concept of One Health and involving otherinternational entities (FAO, OIE, WTO and Unep). Content analysis and various analytical frameworks, considering two economic sectors (the livestock and pharmaceutical industries), proved relevant to illustrating the complexity of the issue, reinforcing its global importance and acknowledging the extent of antibiotic use in animals and the gaps in technological innovation. As the WHO is not only an important agent for mobilizing the response to AMR at the global level, but – despite a context of de-funding – has guaranteed a budget for action in this area, it is concluded that the public health perspective should prevail in the response to AMR. La resistencia a los antimicrobianos ha demostrado ser uno de los mayores problemas de salud pública en todo el mundo. El propósito de este documento es analizar la formulación de la respuesta negociada por la OMS a la AMR por parte de sus Estados miembros. Se analizaron los informes y las resoluciones producidos en la Asamblea Mundial de la Salud. Los resultados indican que a partir de 2014 se establecieron las condiciones para la aprobación más sólida del Plan de Acción Mundial sobre AMR, que abarca el concepto de Salud Única e involucra a otros organizaciones internacionales (FAO, OIE, OMC y Codex Alimentarius). El análisis de los contenidos de dos sectores económicos sensibles, la agricultura y la industria farmacéutica, demostró ser relevante para ilustrar la complejidad del tema, reforzando su relevancia global, reconociendo el alcance del uso de antibióticos en animales y las brechas en la innovación de las nuevas tecnologías. También se considera que en el proceso de formulación de la respuesta a la AMR, a partir de 2014, se buscaron nuevos mecanismos para garantizar la adhesión de los Estados Miembros de la OMS al Plan de Acción Mundial acordado internacionalmente. A resistência a antimicrobianos (AMR) tem se revelado como um dos maiores problemas para saúde pública no nível global. O objetivo deste artigo foi analisar a formulação da resposta à AMR negociada no âmbito da Organização Mundial da SAíde (OMS) por seus Estados-Membros. Foram analisados os relatórios e resoluções produzidos na Assembleia Mundial da Saúde. Os achados indicam que a partir de 2014 foram estabelecidos condições de possibilidade para a aprovação do Plano de Ação Global em AMR de forma mais robusta, abrangendo o conceito de Saúde Única e envolvendo outros organismos internacionais (FAO, OIE, OMC e Codex Alimentarius). A análise dos conteúdos a partir de dois setores econômicos sensíveis – agropecuária e indústria farmacêutica – se mostrou relevante para ilustrar a complexidade tanto da temática, reforçando sua relevância global, reconhecendo a dimensão do uso de antibióticos em animais e as lacunas em inovação de novas tecnologias. Considera-se também que no processo de formulação de resposta à AMR, a partir de 2014, buscou-se novos mecanismos para assegurar a adesão dos Estados Membros da OMS ao Plano de Ação Global pactuado internacionalmente.Maria Lucia Frizon Rizzotto2020-10-10info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfapplication/pdfhttps://www.saudeemdebate.org.br/sed/article/view/3519Saúde em Debate; Vol. 44 No. 126 jul-set (2020): Saúde em Debate; 607-623Saúde em Debate; Vol. 44 Núm. 126 jul-set (2020): Saúde em Debate; 607-623Saúde em Debate; v. 44 n. 126 jul-set (2020): Saúde em Debate; 607-6232358-28980103-1104reponame:Saude em Debateinstname:Centro Brasileiro de Estudos de Saudeinstacron:CBESporenghttps://www.saudeemdebate.org.br/sed/article/view/3519/1073https://www.saudeemdebate.org.br/sed/article/view/3519/1074Copyright (c) 2022 Saúde em Debatehttp://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessSilva, Rafael Almeida da Oliveira, Beatriz Nascimento Lins de Silva, Luiza Pinheiro Alves da Oliveira, Maria AuxiliadoraChaves, Gabriela Costa 2023-09-01T17:18:23Zoai:ojs.saudeemdebate.emnuvens.com.br:article/3519Revistahttps://www.saudeemdebate.org.br/sed/ONGhttps://www.saudeemdebate.org.br/sed/oairevista@saudeemdebate.org.br2358-28980103-1104opendoar:2025-02-17T13:19:43.796951Saude em Debate - Centro Brasileiro de Estudos de Saudefalse |
dc.title.none.fl_str_mv |
Antimicrobial Resistance: formulation of the response in the global health context RESISTENCIA A LOS ANTIMICROBIANOS: LA FORMULACION DE LA RESPUESTA EN EL ÁMBITO DE LA SALUD GLOBAL Resistência a Antimicrobianos: a formulação da resposta no âmbito da saúde global |
title |
Antimicrobial Resistance: formulation of the response in the global health context |
spellingShingle |
Antimicrobial Resistance: formulation of the response in the global health context Silva, Rafael Almeida da Saúde global. Resistência microbiana a medicamentos. Saúde Única. Indústria agropecuária. Produção de droga sem interesse comercial. Global health. Drug resistance, microbial. One Health. Livestock industry. Orphan drug production. Salud Global Farmacorresistencia microbiana Salud Única Industria Agropecuaria Producción de Medicamentos sin Interés Comercial |
title_short |
Antimicrobial Resistance: formulation of the response in the global health context |
title_full |
Antimicrobial Resistance: formulation of the response in the global health context |
title_fullStr |
Antimicrobial Resistance: formulation of the response in the global health context |
title_full_unstemmed |
Antimicrobial Resistance: formulation of the response in the global health context |
title_sort |
Antimicrobial Resistance: formulation of the response in the global health context |
author |
Silva, Rafael Almeida da |
author_facet |
Silva, Rafael Almeida da Oliveira, Beatriz Nascimento Lins de Silva, Luiza Pinheiro Alves da Oliveira, Maria Auxiliadora Chaves, Gabriela Costa |
author_role |
author |
author2 |
Oliveira, Beatriz Nascimento Lins de Silva, Luiza Pinheiro Alves da Oliveira, Maria Auxiliadora Chaves, Gabriela Costa |
author2_role |
author author author author |
dc.contributor.author.fl_str_mv |
Silva, Rafael Almeida da Oliveira, Beatriz Nascimento Lins de Silva, Luiza Pinheiro Alves da Oliveira, Maria Auxiliadora Chaves, Gabriela Costa |
dc.subject.por.fl_str_mv |
Saúde global. Resistência microbiana a medicamentos. Saúde Única. Indústria agropecuária. Produção de droga sem interesse comercial. Global health. Drug resistance, microbial. One Health. Livestock industry. Orphan drug production. Salud Global Farmacorresistencia microbiana Salud Única Industria Agropecuaria Producción de Medicamentos sin Interés Comercial |
topic |
Saúde global. Resistência microbiana a medicamentos. Saúde Única. Indústria agropecuária. Produção de droga sem interesse comercial. Global health. Drug resistance, microbial. One Health. Livestock industry. Orphan drug production. Salud Global Farmacorresistencia microbiana Salud Única Industria Agropecuaria Producción de Medicamentos sin Interés Comercial |
description |
Antimicrobial Resistance (AMR) has proved to be a major public health problem at the global level. This paper examined the formulation of the response to AMR negotiated through the World Health Organization (WHO) by its Member States. Related WHO reports and resolutions from 1998 to 2019 were analysed. The findings indicate that, from 2014 on, more robust conditions were established for approval of a Global Action Plan on AMR, encompassing the concept of One Health and involving otherinternational entities (FAO, OIE, WTO and Unep). Content analysis and various analytical frameworks, considering two economic sectors (the livestock and pharmaceutical industries), proved relevant to illustrating the complexity of the issue, reinforcing its global importance and acknowledging the extent of antibiotic use in animals and the gaps in technological innovation. As the WHO is not only an important agent for mobilizing the response to AMR at the global level, but – despite a context of de-funding – has guaranteed a budget for action in this area, it is concluded that the public health perspective should prevail in the response to AMR. |
publishDate |
2020 |
dc.date.none.fl_str_mv |
2020-10-10 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://www.saudeemdebate.org.br/sed/article/view/3519 |
url |
https://www.saudeemdebate.org.br/sed/article/view/3519 |
dc.language.iso.fl_str_mv |
por eng |
language |
por eng |
dc.relation.none.fl_str_mv |
https://www.saudeemdebate.org.br/sed/article/view/3519/1073 https://www.saudeemdebate.org.br/sed/article/view/3519/1074 |
dc.rights.driver.fl_str_mv |
Copyright (c) 2022 Saúde em Debate http://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Copyright (c) 2022 Saúde em Debate http://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
Maria Lucia Frizon Rizzotto |
publisher.none.fl_str_mv |
Maria Lucia Frizon Rizzotto |
dc.source.none.fl_str_mv |
Saúde em Debate; Vol. 44 No. 126 jul-set (2020): Saúde em Debate; 607-623 Saúde em Debate; Vol. 44 Núm. 126 jul-set (2020): Saúde em Debate; 607-623 Saúde em Debate; v. 44 n. 126 jul-set (2020): Saúde em Debate; 607-623 2358-2898 0103-1104 reponame:Saude em Debate instname:Centro Brasileiro de Estudos de Saude instacron:CBES |
instname_str |
Centro Brasileiro de Estudos de Saude |
instacron_str |
CBES |
institution |
CBES |
reponame_str |
Saude em Debate |
collection |
Saude em Debate |
repository.name.fl_str_mv |
Saude em Debate - Centro Brasileiro de Estudos de Saude |
repository.mail.fl_str_mv |
revista@saudeemdebate.org.br |
_version_ |
1824322520778539008 |